These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2017446)

  • 1. Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9- to 12-day-old rat pups.
    Smith GP; Tyrka A; Gibbs J
    Pharmacol Biochem Behav; 1991 Jan; 38(1):207-10. PubMed ID: 2017446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CCK antagonists on CCK-induced suppression of locomotor activity in mice.
    Hirosue Y; Inui A; Miura M; Nakajima M; Okita M; Himori N; Baba S; Kasuga M
    Peptides; 1992; 13(1):155-7. PubMed ID: 1620653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous cholecystokinin reduces feeding in young rats.
    Weller A; Smith GP; Gibbs J
    Science; 1990 Mar; 247(4950):1589-91. PubMed ID: 2321020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent effects of CCK and devazepide in male and female rats.
    Salorio CF; Hammond PB; Schwartz GJ; McHugh PR; Moran TH
    Physiol Behav; 1994 Oct; 56(4):645-8. PubMed ID: 7800726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
    Crawley JN
    J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Brain Res; 1991 May; 549(1):151-4. PubMed ID: 1893248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
    Vasar E; Stephenson JD; Meldrum BS
    Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loxiglumide, L-364,718 and L-365,260 prevent the inhibition of spontaneous acetylcholine release from the frontal cerebral cortex of freely moving rat peripherally administered with cholecystokinin-8S.
    Kimura I; Wakasono S; Kimura M
    Jpn J Pharmacol; 1995 May; 68(1):129-32. PubMed ID: 7494376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor mediation of the stimulus properties of cholecystokinin.
    Melton PM; Riley AL
    Pharmacol Biochem Behav; 1994 May; 48(1):275-9. PubMed ID: 8029299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
    Vasar E; Harro J; Lang A; Pôld A; Soosaar A
    Psychopharmacology (Berl); 1991; 105(3):393-9. PubMed ID: 1798834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Devazepide alters meal patterns in lean, but not obese, male Zucker rats.
    Strohmayer AJ; Greenberg D
    Physiol Behav; 1994 Nov; 56(5):1037-9. PubMed ID: 7824568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
    O'Neill MF; Dourish CT; Iversen SD
    Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
    Weatherford SC; Chiruzzo FY; Laughton WB
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat.
    Kawabata S; Kanayama S; Shinomura Y; Miyazaki Y; Imamura I; Moriwaki K; Wada H; Tarui S
    Regul Pept; 1991 Jul; 35(1):1-10. PubMed ID: 1924892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors.
    Dourish CT; Ruckert AC; Tattersall FD; Iversen SD
    Eur J Pharmacol; 1989 Dec; 173(2-3):233-4. PubMed ID: 2625140
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulatory role for CCK-B antagonists in Parkinson's disease.
    Boyce S; Rupniak NM; Tye S; Steventon MJ; Iversen SD
    Clin Neuropharmacol; 1990 Aug; 13(4):339-47. PubMed ID: 1976438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK-A receptors mediate the effect of cholecystokinin on vasopressin but not on cortisol in pigs.
    Parrott RF; Forsling ML
    Am J Physiol; 1992 Jun; 262(6 Pt 2):R1154-7. PubMed ID: 1621871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.